Yeast aspartic protease 3 (Yap3) prefers substrates with basic residues in the P2, P1 and P2′ positions  by Ledgerwood, Elizabeth C. et al.
FI-BS 16833 FEBS Letters 383 (1996) 67-71 
Yeast aspartic protease 3 (Yap3) prefers substrates with basic residues in 
the P2, P1 and P2' positions 
Elizabeth C. Ledgerwood a'*, Stephen O. Brennan a, Niamh X. Cawley b, Y. Peng Loh b, 
Peter M. George  ~ 
~Molecular Pathology Laboratory, Clinical Biochemistry, Christchurch Hospital, Christchurch, New Zealand 
bLaboratory of Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, 
Bethesda, MD 20892, USA 
Received 8 February 1996 
Abstract The yeast aspartic protease Yap3 is localised to the 
secretory pathway and correctly cleaves pro-a-mating factor at 
its dibasic sites. We determined the specificity of Yap3 for 
mono-, di- and multi-basic cleavage sites in the context of 15 
residue synthetic proalbumin peptides. Yap3 cleaved after dibasic 
ArgArg and LysArg sites but not after monobasic Arg sites even 
when there was an additional arginine at -6  and/or -4 .  Yap3 did 
not cleave a tetra-arginine site and tribasic sites (RRR and RRK) 
were poor substrates. Cleavage always occurred C-terminal to 
the last arginine in the di- or tri-basic sequence. The optimal 
cleavage site sequence was RR ~DR and this substrate was 
cleaved 8-9-fold faster than the normal RR $ DA sequence. In 
contrast to Kex2, Yap3 did not remove the propeptide from 
normal proalbumin or a range of natural or recombinant 
proalbumin variants. However at pH 4.0 Yap3 slowly cleaved 
proalbumin and albumin between domains 2 and 3. 
K~,y words: Proalbumin processing; Yeast; Aspartic 
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1. Introduction 
stimulating hormone [7]. Anglerfish PSS-I and -II each have a 
dibasic and a monobasic site and cleavage at these sites re- 
suits in the production of somatostatin-14 (SS-14) and soma- 
tostatin-28 (SS-28) respectively. Truncated Yap3 cleaved at 
the dibasic ArgLys site in aPSS-I releasing SS-14 and 
Lys-ISS-14, and at the monobasic Arg in aPSS-II releasing 
SS-28 [8]. However a membrane associated Yap3, overex- 
pressed in S. cerevisiae, cleaved solely C-terminal to arginines 
to produce Lys-lSS-14 from aPSS-I and SS-28 from both 
aPSS-I and -II [9]. 
To date the in vitro analyses of Yap3 have not completely 
defined its specificity, in particular it is unclear whether Yap3 
has a preference for paired- or mono-basic sites, and whether 
it is able to recognise a similar range of sequence motifs to the 
members of the Kex2/furin family. We have previously shown 
that the albumin propeptide RGVFRR is specifically cleaved 
from the N-terminal of proalbumin by Kex2 in vivo and in 
vitro [10-12]. In this study we investigate the specificity of 
Yap3 in vitro using a series of synthetic proalbumin peptides 
and natural and recombinant proalbumin variants. 
The yeast Saccharomyces cerevisiae is a well established 
el&aryotic model for studying limited endoproteolysis at sites 
marked by pairs of basic amino acid residues. In S. cerevisiae 
t~e KEX2 gene encodes a serine protease which processes pro- 
ct factor and pro-killer toxin during their transit through the 
secretory pathway (for reviews see [1-3]). A second non-essen- 
tial gene encodes another potential processing enzyme, Yap3 
Ca east aspartic protease 3), a 569 residue protein capable of 
p~ocessing pro-et-mating factor when the propheromone is
o',erexpressed in KEX2 deficient S. cerevisiae [4]. Recently a 
tt ird novel proprotein processing aspartic protease, MKC7, 
has been cloned from S. cerevisiae [5]. Antibodies directed 
a~;ainst Yap3 recognise an aspartic protease in bovine pitui- 
t~ury intermediate lobe secretory granules [6]. Thus, just as 
K ex2 was the first eukaryotic subtilisin-like convertase, it is 
li'~:ely that Yap3 is the prototype of a family of mammalian 
a:partic proprotein processing endoproteases. 
A truncated form of Yap3 has been overexpressed in S. 
c¢revisiae and the resulting 68000 Da soluble glycoprotein 
plrified and characterised by its ability to cleave mouse 
pvo-opiomelanocortin (POMC) and anglerfish prosomatosta- 
tias I and II (aPSS-I and aPSS-II) in vitro. Yap3 specifically 
cleaved between and after paired basic residues in POMC to 
g~nerate adrenocorticotropin, 13-endorphin and 73-melanocyte 
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2. Materials and methods 
2.1. Expression and partial purification of Yap3 
Yap3 was overexpressed in Saeeharomyces rev&iae strain BJ3501 
and purified from the culture medium as previously described [8]. 
Briefly the secreted Yap3 activity was partially purified by concana- 
valin A affinity chromatography. The Con A column eluate was de- 
salted on a PD-10 column and concentrated. The concentration was 
determined by quantitative Western blot analysis to be 1.9 pmol/I.tl 
and the enzyme was stored at -80°C. 
2.2. Assays with synthetic proalbumin peptides 
Synthetic peptide substrates based on the N-terminal sequence of 
human proalbumin were obtained from Chiron Mimotopes, Victoria, 
Australia. The peptides were 15 residues long and had blocked N- 
(acetyl) and C- (amide) terminals. Tryptophan rather than the normal 
histidine was incorporated atposition +9 to facilitate identification of
the N- and C-terminal cleavage products. The reaction mixture con- 
tained 0.5 nmol proalbumin peptide in 0.1 M sodium citrate pH 4.0 
with 95 or 19 fmol Yap3 in a total volume of 4.5 l.tl. Reactions were 
incubated for specified times, of up to 8 h, at 37°C and stopped by the 
addition of 50 lal buffer A (see below). For the determination f the 
pH optimum the following buffers were used: 50 mM sodium acetate, 
1 mM Ca 2+ pH 4.0, 4.5, 5.0 and 5.5; 50 mM 2-(N-morpholino)etha- 
nesulfonic acid (MES), 1 mM Ca 2÷ pH 5.0, 5.5 and 6.0. After micro- 
fuging 40 ttl was injected on to a 3 ~tm Nova Pac C-18 column and the 
extent of hydrolysis determined by HPLC. The solvent system was: 
buffer A, 49 mM potassium phosphate pH 2.9; B, equal mixture (1:1) 
of buffer A plus acetonitrile. The flow rate was 1 ml/min and the 
gradient went from 16% to 45% B over 14 min. Absorbance was 
monitored at 215 and 254 nm. To compensate for any slight varia- 
tions in injection volumes between runs the reaction rate was calcu- 
lated as % conversiordmin. This was expressed as peak height of C- 
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Fig. 1. Reverse phase HPLC showing cleavage of proalbumin peptides by Yap3. 0.5 nmol peptide was incubated with either 19 fmol (+2R pep- 
tide) or 95 fmol (normal, -2K  and +IH  peptides) Yap3 as described in section 2.2. The HPLC traces above show the 1 h time point for each 
labelled peptide. P, parent peptide; C, C-terminal fragment; N, N-terminal fragment. 
terminal product divided by (height C-terminal product + height par- 
ent peptide). Amino acid analysis and PTH N-terminal sequence ana- 
lysis were used to confirm the identity of the cleavage products. 
2.3. Determination of kinetic parameters 
For four of the proalbumin peptides (normal, -2K ,  +2R and +IH) 
Vm~ and Km were determined by the Lineweaver-Burk method [13]. 
The concentration of the peptide in the assay was varied from 
4x  10 -4 to 2.2x 10 -5 M under conditions such that the formation 
of product was linear over time. Kcat was calculated as VmJ[E]T 
where [E]T is the total enzyme concentration. As the total protein 
concentration rather than active enzyme concentration was used in 
this calculation the kcat values may be underestimated although the 
comparisons will still be valid. 
2.4. Assays with proalbumin and albumin 
Normal human proalbumin was purified from the plasma of an 
individual with antitrypsin Pittsburgh as previously described [14]. 
Proalbumin (30 pmol) was incubated with Yap3 (0.19 pmol) in 0.1 
M sodium citrate pH 4.0 in a total volume of 5 gl at 37°C. The 
reactions were stopped after 16 h by the addition of pepstatin A to 
50 gg/ml. Proalbumin was incubated with Kex2 as previously de- 
scribed [10]. Reactions were analysed in 1% agarose gels using Tris- 
barbital buffer pH 8.6 [14]. 
Normal human serum albumin was purified from plasma [15] and 
75 pmol was incubated with Yap3 (0.38 pmol) in 0.1 M sodium citrate 
pH 4.0 in a total volume of 5 gl at 37°C for 24h. The reaction was 
analysed by reducing SDS PAGE [16]. 
3. Results 
I ncubat ion  o f  Yap3  with the synthet ic  pept ide 
RGVFRRDAHKSEVAW represent ing the propept ide  cleav- 
age site with in proa lbumin  resulted in its specific hydro lys is  at 
the R -1 D +1 bond to generate the N-  and  C- termina l  frag- 
ments  shown in Fig. 1. The  ident i ty o f  these peaks as 
RGVFRR and  DEAKSEVAW was establ ished by amino  
acid analys is  and  PTH sequence analys is  respectively. Com-  
plete c leavage at this site was at ta ined after 4.5 h and  there 
was no  fur ther  hydro lys is  o f  the products  after this t ime. The  
initial c leavage rate, V0, for this pept ide was 0.33 + 0.02 pmol /  
Table 1 
Sequences and relative rates of cleavage of proalbumin peptides by Yap3 
Peptide Peptide sequence Relative rate* 
normal Ac-R G V F R R D A H K S E V A W-NH2 100 _+ 6 
-2K  - K . . . .  97 _+ 7 
+2R - R - - - 855_+40 
-6A  A . . . . . .  69 + 3 
-4E  - - E . . . . . . . .  50 _+ 3 
+2E - - - E . . . .  58 _+ 4 
+ IK  - K . . . . .  18_+1 
+IH - - H . . . . .  12_+0.4 
-3R  - - - R . . . . . .  7_+0.2 
-4R-3R R R . . . .  0 
-2H . . . .  H - - - 0 
-4R-2H R H . . . . . .  0 
-2A  . . . .  A . . . . . .  0 
-4R-2A R - A . . . . .  0 
normal Ac-R G V F R R D A H K S E V A W NH2 I00 + 6 
--6 --5 --4 --3 --2 1 +1 +2 +3 +4 +5 +6 +7 +8 
*Rate (%)_+ 1 S.D. relative to cleavage of the normal peptide. 
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F~g. 2. pH dependence of Yap3. Yap3 (95 fmol) was assayed with 
the -2K peptide (0.5 nmol) for 3 h in Na acetate buffer (z~) or 
M ES buffer (O) at different pH values. 
s~ ;gmol Yap3 and the reaction was completely inhibited by the 
presence of 50 ~tg/ml pepstatin A (not shown). 
A further group of 13 synthetic proalbumin peptides with 
st bstitutions N- and C-terminal to the cleavage site (Table 1) 
x~ ere also tested as potential substrates for Yap3. In each case 
x~ here there was hydrolysis, sequence analysis of the C-term- 
i la l  product confirmed that cleavage had occurred after the 
s~ residue propeptide (not shown). Extended incubations of 
either 4 or 8 h did not result in any additional cleavage of 
either the parent peptides or the N- and C-terminal products. 
! ~ was determined for each peptide in a series of time course 
e:,periments and Table 1 shows the relative initial cleavage 
r~te of each variant peptide compared to the normal peptide. 
To more definitively investigate the reasons for the differ- 
e~ces in cleavage rates, kinetic parameters were determined 
f.,r four of the peptides with average (normal and -2K) ,  
slow (+IH) and fast (+2R) relative cleavage rates (Table 2). 
q he +2R peptide, which was the preferred Yap3 substrate in 
the relative rate experiments, had a higher Km than the other 
s~lbstrates, but this was compensated for by a higher Vm~,. 
q he slow rate of cleavage of the + 1H peptide was entirely due 
t,~ the much lower Vm~ for this substrate. 
The pH optimum of Yap3 cleavage was determined using 
the -2K  proalbumin peptide. Previous reports using either 
POMC or aPSS as substrates indicated an optimum of 4.0- 
4 5 [7,8], however in the present study we found the enzyme 
~ as optimally active at pH 5.5 (Fig. 2), with only 30% activity 
a : pH 4.0. The assays in this study were however performed at 
F H 4.0 to allow direct comparison with the specificities re- 
Forted for Yap3 using other substrates at pH 4.0. 
The yeast Kex2 protease rapidly cleaves the RGVFRR pro- 
F.eptide from human proalbumin to generate the more anodal 
band of mature albumin (Fig. 3A, lane 3). However, while 
ap3 cleaved the synthetic peptide containing the propeptide 
s~'quence, it did not recognise this site in full length normal 
t!uman proalbumin (Fig. 3A, lane 2). This was despite the 
iacubations with proalbumin having a 33-fold higher enzy- 
] le : substrate ratio compared to the assays with the synthetic 
" able 2 
l, inetic parameters for processing by Yap3 
peptides, A number of natural proalbumin variants 
( -2Arg  ~ His, - 1Arg ~ Gln, -2Arg--* Cys, + 1Asp ~ Val) 
[17] and recombinant proalbumin variants ( -4Va l~Arg ,  
-2Arg  ~ Lys, -4Val  ~ Arg-2Arg ~ His, + 1Asp ~ Arg) [10] 
were also tested as substrates for Yap3 (not shown). Yap3 
did not release the propeptide from any of these variants. 
Interestingly Yap3 did cleave both albumin and proalbumin 
at a site distant from the propeptide to generate a more cath- 
odal band (Fig. 3A, lane 2). This reaction was inhibited by 
pepstatin A and occurred at pH 4.0 but not at pH 5.5 (not 
shown). When analysed by reducing SDS PAGE (Fig. 3B, 
lane 2) this fragment was determined to have an MI. of 47 
kDa, and it had the same N-terminal sequence as the starting 
material suggesting that cleavage was occurring between do- 
mains 2 and 3 of albumin. Faint lower molecular weight 
bands were visible at 24 kDa and 16 kDa but these did not 
account for the entire C-terminal product and we have not 
been able to determine the precise cleavage site. There was 
also minor cleavage of albumin incubated in the absence of 
Yap3 producing a 47 kDa band (Fig. 3B, lane 1). This is most 
likely due to partial acid hydrolysis at the single Asp-Pro 
bond in albumin [18,19]. 
4. D iscuss ion  
A diverse range of mammalian proproteins including neuro- 
peptides, peptide hormones, plasma proteins and receptors are 
subjected to specific intracellular cleavage at basic sequences in
order to generate biologically active forms. The characterisa- 
tion of the yeast Kex2 protease and the gene that encodes it has 
led to the discovery of a family of homologous mammalian 
convertases [20,21]. Like Kex2 the Yap3 protease from S. cere- 
visiae is a membrane bound enzyme located in a post-ER com- 
partment of the yeast secretory pathway [6,22] and as such has 
a potential role in precursor processing. Here, using a series of 
synthetic proalbumin peptides, we have analysed the specificity 
of a truncated soluble form of Yap3. 
Both the ArgArg proalbumin peptide and the LysArg 
proalbumin peptide were good substrates for Yap3 and in 
each case cleavage occurred exclusively on the C-terminal 
side of the dibasic site. The peptides with the monobasic His- 
Arg and AlaArg sequences were not cleaved despite there 
being an arginine at -6  which has been suggested to be im- 
portant for monobasic processing by Yap3 in aPSS-II [8]. In 
addition a -4  arginine did not enable processing of either of 
these monobasic sites. This is in stark contrast o furin which 
cleaves the -4R-2A peptide 80-fold faster than the -2A  
peptide (Ledgerwood, Brennan, Birch, Nakayama and 
George, submitted). Tribasic sequences were poor substrates, 
the ArgArgArg -1 peptide being cleaved at only 7% the rate of 
normal and the ArgArg-lLys +1 sequence at 18%. Interest- 
ingly in the former cleavage was after the third arginine and 
in the latter it was between the arginine and the lysine. The 
common mammalian tetrabasic motif (ArgArgArgArg -1) was 
Vmax (pmol S -1) K m (mol/l) kc~t (s -1) kcat/Km ((mol/l)-I "s t) 
i~ormal 13.9 4.8x 10 4 7.4 1.5X 10 4 
- 2K 2.1 1.1x l0  4 1.1 1 .0x104 
- 2R 46 7.8x 10 -4 24.4 3.1 x 104 
- 1H 0.15 0.5× 10 -4 0.08 0.16× 104 
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Fig. 3. Cleavage of human proalbumin and albumin by yeast proteases. A: Agarose gel electrophoresis. Proalbumin was incubated with either 
Yap3 (lane 2) or Kex2 (lane 3) as described in section 2.4. Lanes 1 and 4, proalbumin and albumin standards respectively. Anode at top. 
B: 12.5% reducing SDS PAGE. Albumin was incubated either alone (lane 1) or with Yap3 (lane 2) as described in section 2.4. Position of mo- 
lecular weight markers (kDa) shown at right. 
not cleaved by Yap3. Yap3 was also sensitive to changes that 
did not involve the paired basic residues. Acidic residues were 
unfavourable at either -4  or +2, decreasing the processing 
rate by about half. Replacing the aspartic acid at +1 with 
histidine had a similar effect to the substitution of lysine at 
this position with slow processing occurring between the argi- 
nine and the histidine. Although the -6  arginine did not 
enable Yap3 to cleave at a monobasic site it did contribute 
to dibasic processing since replacing it with alanine decreased 
the cleavage rate by 30%. 
The most striking feature of this enzyme's pecificity was 
the nine-fold enhancement in hydrolysis that occurred when 
the alanine at +2 was replaced with an arginine. This prefer- 
ence for substrates of sequence ArgArg $ XArg is in marked 
contrast o furin and PC3 where a +2 arginine completely 
prevents hydrolysis (Ledgerwood, Brennan, Birch, Nakayama 
and George, submitted). Cleavage of the +2R peptide oc- 
curred at a catalytic efficiency similar to that observed for 
cleavage of the proinsulin B/C junction and cholecystokinin 
by Yap3 [23]. In agreement with Bourbonnais et al. [9] our 
results indicate that Yap3 has a preference for cleaving on the 
C-terminal side of the last arginine in di- or tri-basic se- 
quences. However in ACTH 1-39 efficient cleavage occurred 
between the lysines in the LysLysArgArg sequence generating 
ACTH ~-15 and CLIP 16-39 [7]. Interestingly in this configura- 
tion the LysLys bond has an arginine in the +2 position which 
may direct cleavage to the LysLys site. 
The contrasting results obtained from the synthetic proal- 
bumin peptide compared to full length proalbumin highlights 
the dangers of extrapolating the results obtained with repre- 
sentative peptides to the full length proteins. This may explain 
the differences in the published results describing Yap3 pro- 
cessing of aPSS I and II since in one case full length proteins 
were used [8] whereas the other study used shorter synthetic 
peptides [9]. The results of the present study demonstrate hat 
it is not only the primary sequence that determines specificity 
but the conformation at the processing site also effects the rate 
of reaction. It is likely that there are significant structural 
differences between a short peptide and a full length protein 
which explain the differential processing of the synthetic pep- 
tides compared to proalbumin. 
The inability of Yap3 to remove the propeptide from hu- 
man proalbumin in vitro is consistent with our previous find- 
ing that proalbumin is secreted unprocessed from a kex2-  
strain of S. cerevisae [10]. Also there was no evidence of clea- 
vage occurring between domains 2 and 3 when proalbumin 
was expressed in S. cerevisae. This presumably is because 
Yap3 only cleaves at this site when albumin undergoes a
pH dependent N~ F conformational change. This only oc- 
curs below pH 4.5 and results in unfolding of the C-terminal 
domain making alternate sequences available for potential 
proteolysis [19]. 
The two yeast proteases Kex2 and Yap3 have different spe- 
cificities and presumably complimentary functions in vivo. 
Although both are localised to the secretory pathway their 
different pH optima (5 5.5 for Yap3, 6-8 for Kex2 [11]) 
mean they are unlikely to be active in the same compartment. 
To date two aspartic proteases that are potentially involved in 
E.C. Ledgerwood et al./FEBS Letters 383 (1996) 6~71 
proprotein processing have been identified in higher eukar- 
yotes in bovine pituitary intermediate and neural lobes 
and in anglerfish secretory granules [24,25]. One of these 
(the pituitary proopiomelanocortin converting enzyme) is im- 
mtmologically related to Yap3 [6] suggesting Yap3 might be a 
prototype of a family of proprotein convertases. However as 
yc~ no mammalian homologues have been cloned. 
1"o date it is not known whether there is a hepatic aspartic 
pJ otease homologous to Yap3. The present study suggests 
that if there is such a protease, it will not be involved in 
p~ oalbumin processing. It is also unlikely to cleave the major- 
i t  of known liver proproteins which have unfavourable 
- l , -4  or -1 , -2 , -4  multibasic processing site sequences. 
Jt~st as characterising the Kex2 protease provided the initial 
insights into the homologous family of mammalian enzymes, 
fi:rther study of Yap3, including identification of potential 
s~ bstrates, should provide important insights into the activity 
o! this new family of proprotein processing endoproteases. 
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